ShareValue scores for RHY.AU: Valuation 37, Quality 34, Growth 24, Health 48.

RHYTHM Biosciences Ltd logo

RHY.AU
ASX

RHYTHM Biosciences Ltd

A$0.10(+5.43%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-8% to 10%
Valuation
37
Overvalued
Price vs Value
Quality
34
Weak
Business Strength
Growth
24
Weak
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
32
Bearish
Price Trend

Company Details

About

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026